adult clinical studies, page-3

I would disagree DMAN,
We now have more exposure, and are closer to FDA submission.


Good adult results completely removes concerns that we may fail on this front with regards to FDA submissions. They will also pave the way for other contracts that are not FDA binding, such as WHO partnership, to be formed and announced.

Last year the stock was still regarded as highly speculative, while now the signs are emerging more and more that this is the real deal and that big players and hospitals want to use it eg cap raise money and Wesley TV broadcast.

Cheers
CT